Skip to main content
. 2014 Feb 1;24(2):277–286. doi: 10.1089/thy.2012.0654

Table 1.

Clinical Characteristics According to Prognosis

  Good prognosisa(n=78) Poor prognosisb(n=74) p
Mean age at diagnosis (years) 39.1±17.3 52.3±13.0 <0.001
Male:female (male %) 13:65 (16.7) 20:54 (27.0) 0.121
Pathology of primary tumor
 Size (cm) 2.4±1.7 3.3±2.0 0.015
 PTC:FTC (FTC %) 70:8 (10.3) 55:19 (25.7) 0.012
 Multiplicity, present % 40.0 48.6 0.443
 Extrathyroidal invasion, gross, present % 27.8 30.8 0.783
 LN metastasis, present % 42.6 58.5 0.123
Timing of metastasisc     <0.001
 Pre-op, n (%) 3 (27.3) 8 (72.7)  
 Immediate, n (%) 53 (67.1) 26 (32.9)  
 Late, n (%) 22 (35.5) 40 (64.5)  
Sites of metastasis
 Lung only:multiple (multiple %) 73:3 (3.9) 52:18 (25.7) <0.001
Pattern of lung uptake in WBS   <0.001
 Bilateral diffuse, n (%) 35 (89.7) 4 (10.3)  
 Focal, n (%) 27 (57.4) 20 (42.6)  
 Nonavid, n (%) 6 (15.0) 34 (85.0)  
Size of lung lesions from radiologic examd    
 Micro:macro (macro %) 13:12 (48.0) 8:50 (86.2) <0.001
a

Good prognosis: no evidence of disease or stable disease.

b

Poor prognosis: progression of disease or death.

c

Pre-op: lung metastasis diagnosed during initial preoperative work-up; immediate: metastasis diagnosed by WBS during initial 131I remnant ablation; late: diagnosed by WBS or radiologic examination performed due to the increases of T4-suppressed Tg or stimulated (off T4) Tg after initial evaluation or 131I remnant ablation.

d

Micro: micronodule, where the largest size of the nodule is <1 cm; macro: macronodule, where the largest size of the nodule is ≥1 cm.

FTC, follicular thyroid carcinoma; LN, lymph node; PTC, papillary thyroid carcinoma; T4, thyroxine; WBS, whole-body scan.